Upmodulation of αvβ1 integrin expression on human tumor cells by human interleukin for DA cells/leukemia inhibitory factor and oncostatin M: Correlation with increased cell adhesion on fibronectin
✍ Scribed by Dominique Heymann; Jean Harb; Sophie Ringeard; Fréadéric Blanchard; Danielle Lassort; Sylvie Raher; Anne Godard
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 972 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Integrins belong to a large family of heterodimeric membrane glycoproteins which mediate cell‐cell or cell‐extracellular matrix interactions. These interactions could play a major role during the migration of tumor cells across the extracellular matrix and vascular endothelium and would thus appear to be requisite for the metastatic process. Pretreatment of the Foss human melanoma cell line with HILDA/LIF or OSM, two cytokines involved in acute‐phase response, increased the expression of membrane αvβ1 1.5–2‐fold. The same phenomenon was observed on the SK‐N‐SH human neuroblastoma cell line. αvβ1 upmodulation was concomitant with improved tumor cells attachment to the fibronectin matrix. This greater adhesion of tumor cells to fibronectin was inhibited by specific monoclonal antibodies against αv or β1 integrin subunits. Similar results were obtained after TNF‐α treatment. Our findings demonstrate the ability of HILDA/LIF and OSM to modulate tumor cell capacity to adhere to the matrix component, suggesting a potential role for these cytokines in modulation of tumoral progression.